Clinical Trial Update: Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria [Phase 2]

View source ↗

Summary

Phase 2 controlled trial of Panhematin for acute attacks of porphyria has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Porphyrias

Drugs mentioned

• Panhematin (heme arginate (hemin))

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Acute Porphyrias | Phase 2 | Status: COMPLETED | Results posted: 2025-04-03